Stryker Corp. (SYK) Company Profile & Statistics

Stryker Corp.
SYK
(NYSE)
N/A
337.42
+0.27 (+0.08%)
in:usd•As of: Apr 26, 2024 14:13 UTC -4
Open
335.84
High
338.48
Low
334.25

About Stryker Corp.

CEO

Kevin A. Lobo

Headquarters

1941 stryker way

portage, mi 49002, united states

Auditor

Ernst & Young LLP

Employees

52,000

Share Holders

2,501

Website

www.strykercorp.com

Industry

medical specialties

Sector

health technology

Company Overview

Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.

Stryker Corp. Statistics

Valuation Measures

Market Capitalization ²	128.38B
Enterprise Value	138.40B
Enterprise Value/EBITDA (ttm)	28.15
Price to Earnings Ratio (ttm)	31.78
Price to Book (mrq)	6.88
Price to Sales (ttm)	6.25
Price to Cash (ytd)	25.12

Profitability

Gross Margin (ttm)	63.70%
Operating Margin (ttm)	19.84%
Profit Margin (ttm)	15.23%
Return on Equity (ttm)	22.99%
Return on Invested Capital (ttm)	10.97%
Return on Assets (ttm)	10.69%

Income Statement

Revenue (ttm)	20.50B
Revenue Per Share (ttm)	53.90
Gross Profit (ttm)	13.06B
EBITDA (ttm)³	4.92B
Net Income Avi to Common (ttm)	3.17B
Diluted EPS (ttm)	8.25

Share Statistics

Beta (5Y Monthly)	0.89
52-Week Change	14.09%
S&P500 52-Week Change	25.99%
S&P500 Member	Yes
Stock Optionable	Yes
Total Shares Outstanding ¹	380.26M
Dividend Yield	0.95%
Float ⁴	358.02M
% Held by Insiders	5.90%
% Held by Institutions	77.09%

Balance Sheet

Total Cash (mrq)	3.05B
Total Cash Per Share (mrq)	8.03
Total Debt (mrq)	12.99B
Total Debt/Equity (mrq)	69.89%
Current Ratio (mrq)	1.58%
Quick Ratio (mrq)	0.97%
Book Value Per Share (mrq)	48.92

Cash Flow

Operating Cash Flow Per Share (ytd)	9.67
Free Cash Flow (ytd)	3.14B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Stryker Corp.

Trade With A Regulated Broker